Skip to main content
Premium Trial:

Request an Annual Quote

Start-Up Focus

To bolster its life science sector, New York City should focus on start-up companies, real estate developer Joel Marcus tells the Financial Times.

Marcus, FT adds, is the chair and co-founder of Alexandria Real Estate Equities, which builds and owns life-science buildings, including the Alexandria Center for Life Science on New York's East Side. But he tells FT that while New York has the medical and life science resources, he says the city is too expensive for larger firms and should concentrate on incubating smaller firms that then may expand elsewhere. "You can't really scale a company in substantial fashion here in New York like you can in other locations," Marcus tells it.

It notes that Marcus's comments come as New York Mayor Eric Adams touts the life science sector as a means of growth and jobs for the city as it rebounds from the COVID-19 pandemic.

FT adds that Orin Herskowitz, the executive director of Columbia Technology Ventures, disagrees, and instead says that New York is catching up to other life science hubs.

Filed under

The Scan

Open Pediatric Brain Tumor Atlas Team Introduces Genomic Data Collection, Analytical Tools

A study in Cell Genomics outlines open-source methods being used to analyze and translate whole-genome, exome, and RNA sequence data from the Pediatric Brain Tumor Atlas.

Neurological Outcomes Linked to Innate Immune Features After Cardiac Arrest

Researchers reporting in Med dig into immune features found a few hours after cardiac arrest that correspond with neurological outcomes.

Mouse Study Finds Circadian Rhythm-Related Gene Expression Changes Linked to Sleep Apnea

A paper in PLOS Biology reveals tissue-specific circadian rhythm and gene expression patterns in an intermittent hypoxia-based mouse model of obstructive sleep apnea.

Polygenic Risk Score to Predict Preeclampsia, Gestational Hypertension in Pregnant Women

Researchers in Nature Medicine provide new mechanistic insights into the development of hypertensive disorders of pregnancy, which may help develop therapeutics.